Matthew Larson proposes sale of 143,750 SLDE shares (NASDAQ: SLDE)

Rhea-AI Filing Summary

Matthew Larson reported a proposed sale of 143,750 common shares of the company in a Form 144 submission. The filing lists the transaction as an Exercise of Stock Options with cash consideration on 03/03/2026. The filing also discloses prior 10b5-1 sales of 22,500 shares on 02/25/2026 for $427,511.25 and 30,388 shares on 01/05/2026 for $563,776.41.

Insights

Equity Compensation Analyst

Routine insider sale tied to option exercise and 10b5-1 sales; not an earnings event.

The filing records a proposed sale of 143,750 common shares via an Exercise of Stock Options with cash consideration effective 03/03/2026. This is a standard mechanism for converting options to shares prior to resale.

Previous automated sales under a 10b5-1 plan totaled 22,500 and 30,388 shares on 02/25/2026 and 01/05/2026, respectively. Cash proceeds for those trades were $427,511.25 and $563,776.41. Timing and execution of any resale depend on the seller's plan and market activity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	143750	2760000.00	124319406	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/03/2026	Exercise of Stock Options	Issuer			143750	03/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MATTHEW LARSON 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	02/25/2026	22500	427511.25
10b5-1 Sales for MATTHEW LARSON 4221 W. Boy Scout Blvd., Suite 200 Tampa FL 33607	Common	01/05/2026	30388	563776.41

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Matthew Larson's Form 144 for SLDE report?

The Form 144 reports a proposed sale of 143,750 common shares tied to an exercise of stock options with cash consideration on 03/03/2026. It also lists recent 10b5-1 sales in January and February 2026.

How many shares were sold under 10b5-1 plans in recent months for SLDE?

The filing shows two 10b5-1 sales: 22,500 shares on 02/25/2026 for $427,511.25 and 30,388 shares on 01/05/2026 for $563,776.41. These are reported as prior transactions.

Is the 143,750-share item a sale or an option exercise in the SLDE filing?

The entry for 143,750 shares is listed as an Exercise of Stock Options with cash, dated 03/03/2026. The Form 144 shows this as the method associated with the securities to be sold.

Does the Form 144 indicate who receives proceeds from the 143,750-share transaction?

The filing lists the transaction as an Issuer entry and notes Cash as consideration on 03/03/2026. The document ties the action to option exercise; further proceeds treatment beyond that statement is not included in the excerpt.